DBV Technologies Announces Publication of Experimental Data

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy

Publication in Cellular & Molecular Immunology Shows that Desensitization with EPIT ® Induces Tregs with Specific Homing Properties

Compared to Other Methods Studied, Scientific Data Shows that Only EPIT Retains Suppressive Ability After Treatment Discontinuation

Montrouge, France, April 11, 2016 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the publication of experimental data in Cellular & Molecular Immunology characterizing the response of regulatory T cell (Tregs) to allergen-specific immunotherapy intended for the treatment of food allergies. The study characterized Tregs activity during Epicutaneous Immunotherapy (EPIT), oral immunotherapy (OIT) and sublingual immunotherapy (SLIT), and showed that all methods of treatment desensitized peanut-sensitized mice, but only EPIT-induced Tregs continued to show suppressive abilities after treatment discontinuation. DBV Technologies is developing Viaskin®, a proprietary technology that uses EPIT to deliver allergenic compounds targeting the immune system through the immune cells of intact skin, the Langerhans cells in the epidermis.

"Although EPIT, OIT and SLIT were all able to desensitize peanut-allergic mice, only EPIT-induced Tregs maintained suppressive activities after treatment was stopped," explained Dr. Lucie Mondoulet , Deputy Chief Scientific Officer, DBV Technologies. "Knowing that maintaining suppression ability after treatment may lead to the induction of long-term tolerance, we are now working to confirm these experimental data through our ongoing clinical trials with Viaskin." The study, " Differences in Phenotype, homing properties and suppressive activities of Regulatory T cells induced by Epicutaneous, Oral or Sublingual Immunotherapy in Mice Sensitized to Peanut ", showed that peanut desensitization with EPIT, OIT, and SLIT induce different Tregs subsets with differing homing properties, consequently inducing  distinct long-term efficacy and maintenance ability in vivo . The three immunotherapy routes studied were all found to have a desensitization effect, but suppressive activities after discontinuation of treatment were only observed with EPIT, and not with OIT or SLIT. Tregs observed during OIT and SLIT showed only an effector/memory cell profile, while Tregs during EPIT showed both effector/memory and naive cell profiles. These "naive" Tregs appear to induce sustained suppression after discontinuation of treatment, suggesting the induction of a longer-lasting allergen tolerance in a mice model. The study was published in Cellular & Molecular Immunology and is now available via Open Access at http://www.nature.com/cmi/journal/vaop/ncurre...1614a.html .

Food allergies affect approximately 15 million Americans and 17 million Europeans, with the majority of patients being young children. There is currently no approved treatment other than dietary avoidance and the availability of self-injectable epinephrine.

Study Details To study efficacy and characterization of Tregs induced by the different therapies, mice sensitized with peanut protein extract (PPE) were randomly allocated to four groups of eight and treated for eight weeks:  EPIT (100 µg), OIT (1 mg the first week, 2 mg the second week, then 5 mg the following 6 weeks), SLIT (100 µg) and a placebo group.  Allergen specific responses as well as Treg phenotypes were analyzed using blood and tissue samples.  To examine the transfer of protection by Tregs, mice were randomly allocated to six groups of 15 animals and treated for eight weeks:  two groups treated by EPIT, two treated by SLIT and two groups treated by OIT.  Following treatment, or 8 weeks after the end of treatment, one group treated with each form of immunotherapy were sacrificed for spleen cell recovery and CD4 + CD25 + cell sorting. Cells were then transferred into peanut-sensitized non-treated mice (n=8 per group). Three days after the transfer, mice were orally exposed to peanuts daily for 10 days. A tissue analysis of esophagus was then conducted to assess the protection conferred by passive Tregs transfer.

About DBV Technologies 

DBV Technologies is developing Viaskin®, an innovative new approach to the treatment of allergies - a major public health issue that has been increasing in prevalence. DBV Technologies, incorporated in France in 2002, has developed a proprietary, patented technology for administering an allergen to intact skin while avoiding transfer to the blood, and thus lowering the risk of a systemic, allergic reaction in the event of accidental exposure. DBV Technologies is focusing on food allergies, including milk and peanut, for which there are currently no effective treatments. DBV Technologies has designed two products candidates: Viaskin® Peanut and Viaskin® Milk. The clinical development program for Viaskin® Peanut has received Fast Track designation and Breakthrough Therapy designation from the U.S. Food and Drug Administration.

DBV Technologies shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and on the Nasdaq Stock Market in the form of American Depositary Shares (each representing one-half of one ordinary share) (Ticker: DBVT). For more information on DBV Technologies, please visit our website: www.dbv-technologies.com   

Forward Looking Statements

This press release contains forward-looking statements, including statements about the potential safety and efficacy of Epicutaneous Immunotherapy (EPIT®) via Viaskin®.  These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. The Company's product candidates have not been approved for sale in any jurisdiction. Among the factors that could cause actual results to differ materially from those described or projected herein are uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, the risk that historical preclinical results may not be predictive of future clinical trial results, and the risk that historical clinical trial results may not be predictive of future trial results.  A further list and description of these risks, uncertainties and other risks can be found in the Company's regulatory filings with the French Autorité des Marchés Financiers, the Company's Securities and Exchange Commission filings and reports, including in the Company's Annual Report on Form 20-F for the year ended December 31, 2014 and future filings and reports by the Company.  Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release, whether as a result of new information, future events or circumstances or otherwise.

DBV Technologies Contact
Susanna Mesa Senior Vice President, Strategy Tel. : +1 212-271-0861 susanna.mesa@dbv-technologies.com  
DBV Technologies Media Contacts US & Europe 
Marion Janic Rooney & Associates Tel. : +1-212-223-4017 mjanic@rooneyco.com   Erinn White Centron PR Tel. : +1-646-722-8822 ewhite@centronpr.com Caroline Carmagnol Alize RP - Relation Presse Tel. : +33(0)6 64 18 99 59 caroline@alizerp.com

PDF Version http://hugin.info/156437/R/2002409/738952.pdf

HUG#2002409

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 165

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading
Sungrow Puts Storage Safety and Deployment on Display

Updated Category News Views 75

Fire-test footage is not usually the thing that grabs a room in Las Vegas, but Sungrow made it the centerpiece at RE+ 2026 for a reason. Energy storage has no shortage of glossy promises; what it needs is proof that equipment can handle the ugly stuff. Sungrow used the show to pitch a broader North American lineup, yet the PowerTitan 3.0 battery system and its large-scale...

Continue Reading
Albany Masonry Waterproofing Is a Quiet Value Play

Updated Category News Views 114

Winter works its mischief one soaked brick at a time. That is the unglamorous truth behind Sean Mulligan's discussion of masonry waterproofing for Albany-area homes. Brick and stone look tough enough to outlast the furniture, the siding, maybe the whole neighborhood. Yet they are porous materials, and in a region where rain, snowmelt, and sharp temperature swings keep...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 7

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Markel's $2.5 Billion Buyback Adds Capital Flexibility

Updated Category News Views 86

A Large Checkbook, Not a Purchase Order Markel just handed management another $2.5 billion of repurchase firepower, and that deserves attention without the usual buyback cheerleading. The Board approved an increase to the existing authorization on November 18, 2026. That is a meaningful capital-allocation signal from a company built around specialty insurance,...

Continue Reading
Foresite's No. 22 Rank Signals MSSP Growth Momentum

Updated Category News Views 36

Cybersecurity rankings can be a carnival of shiny badges, but No. 22 out of 250 managed security providers is not something a serious buyer should casually brush aside. Foresite Cybersecurity landed there in MSSP Alert's 2026 survey and also made three of the program's new Prestige Top 10 lists: Best Enterprise Focused MSSP, Most Innovative MSSPs, and Fastest Growing...

Continue Reading
Cold Stone’s Holiday Menu Is a Franchisee Traffic Test

Updated Category News Views 88

Peppermint, caramel, and red velvet arrive right when dessert budgets loosen up. Cold Stone Creamery has rolled out a holiday menu running through January 5, 2027, and this is the sort of modest, practical promotion that matters more to a franchise system than the glittery language around it. Nobody should confuse two seasonal ice cream flavors with a corporate...

Continue Reading
Youdao Sets December AGM With No Vote on the Table

Updated Category News Views 74

A shareholder meeting without a vote is more temperature check than showdown, and that is exactly what Youdao has scheduled for December 17, 2026. The company will gather shareholders from 3:00 p.m. to 5:00 p.m. Beijing time at its Beijing office, but it has made one point painfully clear: no proposal will be submitted for shareholder approval. For holders of NYSE: DAO,...

Continue Reading
M.O.L.I.F.E. Brings Community Inclusion Into Public View

Updated Category News Views 23

A food pantry can reveal more about inclusion than a polished mission statement ever will. M.O.L.I.F.E., Inc. is set to be featured in an educational segment of All Access with Andy Garcia, and the useful part of this story is not the celebrity-host packaging. It is the organization’s insistence that employment, independent living, day programming, residential support,...

Continue Reading

Top 5 Most Recently Viewed Articles

Galderma Showcases Innovations in Dermatology at EADV 2024

Updated Category News Views 262

Galderma's Role at EADV 2024 At the upcoming European Academy of Dermatology and Venereology (EADV) congress, Galderma is set to highlight its important advancements in dermatology. This congress serves as a vital platform where dermatology professionals come together to exchange knowledge, explore new insights, and delve into the latest developments within the field....

Continue Reading
Exploring Growth Factors in the Scoliosis Management Sector

Updated Category News Views 131

Growth Potential in the Scoliosis Management Market Recent analyses reveal an exciting trajectory for the global scoliosis management market, projected to reach a remarkable $4.39 billion by 2034. This growth is fueled by an expected compound annual growth rate (CAGR) of 3.7% throughout the period. A significant push behind this bright future comes from the increasing...

Continue Reading
Celebrating 5 Years of Luxury Home Building with JASPER

Updated Category News Views 375

JASPER Marks Five Years of Distinctive Home Building JASPER, Nashville's foremost luxury builder, takes pride in celebrating five remarkable years of creating custom homes and inspiring renovations with a focus on precision, honesty, and a customer-centered approach. Establishing a Reputable Foundation Since its inception, JASPER has become synonymous with quality in...

Continue Reading
La Rosa Holdings Strengthens Agent Platform for Growth

Updated Category News Views 92

La Rosa Holdings Enhances Agent Platform La Rosa Holdings Corp. (NASDAQ:LRHC) has recently unveiled an upgraded version of its proprietary platform, My Agent Account, which includes a new property management module aimed at increasing operational efficiency for its agents. The My Agent Account platform has been gaining traction, evidenced by a remarkable 19%...

Continue Reading
Alkaline Water Company Partners for Expansion in New Markets

Updated Category News Views 153

Alkaline Water Company Enhances Global Presence The Alkaline Water Company, Inc. (OTC: WTER), known for its premium hydration solutions, has recently made significant strides in expanding its international footprint. In a notable move, the company has entered into a strategic international sales and distribution agreement with Global Brand and Export Development, LLC....

Continue Reading